U.S. Markets closed

Balversa Drug Insight Report, 2019: Drug Overview, Mechanism of Action, Clinical Trials, Regulatory Milestones, Deals, Partnerships, and Sales Forecasting to 2021 - ResearchAndMarkets.com

The "Balversa - Drug Insight, 2019" report has been added to ResearchAndMarkets.com's offering.

Balversa - Drug Insight, 2019 report provides comprehensive information of the drug, Balversa. It includes drugs overview, Balversa mechanism of action, clinical trials, regulatory milestones, deals & Balversa's partnerships. It further provides Balversa`s patents (US & EU) and its API manufacturers details in the United States, Europe, China and India.

It also features the historical and forecasted Balversa sales till 2021. The report also throws light on Balversa market competition and emerging therapies in the same space as Balversa. Balversa SWOT analysis is also featured.

Scope of the Report

  • A comprehensive Balversa overview including product description, regulatory milestones, clinical trials, deals and partnerships, have been elaborated in this report
  • Balversa Patent information in United States (US) and Europe (EU) has been highlighted
  • Balversa API manufacturers in United States, Europe, China and India
  • The report contains historical and forecasted Balversa sales till 2021
  • Comprehensive coverage of the emerging therapies (Phase III) in the space where Balversa operates including their product description, research and development activities, collaborations and licensing deals, drug mechanism and chemical information
  • The report also features the Balversa SWOT analysis

Reasons to Buy

  • Establish a comprehensive understanding of the drug, Balversa
  • Access to Balversa API manufacturers details to devise API procurement strategy for generic development
  • Plan developmental timelines around Balversa patents for the major markets- US and EU
  • Understand current and future Balversa`s growth through its historical and forecasted sales
  • Identify and understand the current in-market competitors for Balversa
  • Identify the product attributes and use it for target finding, drug repurposing, and precision medicine
  • Identify and plan ahead for prospective emerging players and their products operating in the same space as Balversa
  • Identify opportunities in the same area as with Balversa SWOT analysis

Key Topics Covered

1. Report Introduction

2. Balversa - Overview

  • Balversa Product Description
  • Balversa Route of Synthesis
  • Balversa Mechanism of Action
  • Balversa Pharmacology
  • Balversa Pharmacodynamics
  • Balversa Pharmacokinetics
  • Balversa Adverse Reactions
  • Balversa Clinical Trials
  • Balversa Regulatory Milestones
  • Balversa Development Activities

3. Global API Manufacturers

  • United States
  • Europe
  • China
  • India

4. Product Details

  • United States
  • Europe

5. Balversa Global Sales Assessment

  • Balversa Sales Global(Historical)
  • Balversa Sales Global(Forecasted)

6. Balversa Patent Details

7. Balversa Market Competition

8. Balversa Emerging Therapies

8.1. Drug name: Company name

  • Product Description
  • Research & Development
  • Product Development Activities

9. Balversa SWOT Analysis

List of Tables

Table 1: Balversa, Description

Table 2: API Manufacturers Region wise

Table 3: API Manufacturers for United States

Table 4: API Manufacturers for Europe

Table 5: API Manufacturers for China

Table 6: API Manufacturers for India

Table 7: Balversa Product Details, United States

Table 8: Balversa Product Details, Europe

Table 9: Balversa, Historical Global Sales till 2017 (in million USD)

Table 10: Balversa, Forecasted Global Sales from 2019-2021 (in million USD)

Table 11: Patent Details: Balversa

Table 12: Balversa Major Competitors

Table 13: Emerging Therapies

List of Figures

Figure 1: Balversa

Figure 2: Balversa, Historical Global Sales till 2017 (in million USD)

Figure 3: Balversa, Forecasted Global Sales from 2019-2021 (in million USD)

Figure 4: Patent Details: Balversa

Figure 5: API Manufacturers Region wise

For more information about this report visit https://www.researchandmarkets.com/r/6vkvaj

View source version on businesswire.com: https://www.businesswire.com/news/home/20191227005270/en/


Laura Wood, Senior Press Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900